Bio Science Animal Health

Equities

BIS

THA776010003

Healthcare Facilities & Services

End-of-day quote Thailand S.E. Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
3.7 ^THB	-3.65%		+8.19%	-24.49%

Apr. 24	Bioscience Animal Health Public Company Limited Approves the Remaining Dividend Payment from the Second Half Six-Month Operating Period 2023, Payable on May 21, 2024	CI
Feb. 28	Bioscience Animal Health Public Company Limited Proposes Dividend for the Second Half Six-Month Operating Period 2023, Payable on May 21, 2024	CI

Bio Science Animal Health Public Company Limited has completed an IPO in the amount of THB 564 million.

May 03, 2022 at 12:00 am EDT

Bio Science Animal Health Public Company Limited has completed an IPO in the amount of THB 564 million.

Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 94,000,000
PriceRange: THB 6

Transaction Features: Reserved Share Offering

Latest news about Bio Science Animal Health

Bioscience Animal Health Public Company Limited Approves the Remaining Dividend Payment from the Second Half Six-Month Operating Period 2023, Payable on May 21, 2024	Apr. 24	CI
Bioscience Animal Health Public Company Limited Proposes Dividend for the Second Half Six-Month Operating Period 2023, Payable on May 21, 2024	Feb. 28	CI
Bioscience Animal Health Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Bioscience Animal Health Public Company Limited Announces Changing of Chief Accountant	Jan. 04	CI
Bioscience Animal Health Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
Bioscience Animal Health Public Company Limited Announces Cash Dividend for the Period from January 1, 2023 to June 30, 2023, Payable on September 08, 2023	23-08-11	CI
Bioscience Animal Health Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Bioscience Animal Health Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
129,525,000 Common Shares of Bio Science Animal Health Public Company Limited are subject to a Lock-Up Agreement Ending on 5-MAY-2023.	23-05-04	CI
Bioscience Animal Health Public Company Limited Resolves to Establish A Subsidiary Beyond Animal Science Company Limited	23-05-02	CI
Bioscience Animal Health Public Company Limited Proposes Cash Dividend for the Year 2022, Payable on May 22, 2023	23-02-27	CI
Bio Science Animal Health Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-26	CI
Bio Science Animal Health Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
43,175,000 Common Shares of Bio Science Animal Health Public Company Limited are subject to a Lock-Up Agreement Ending on 5-NOV-2022.	22-11-04	CI
Bio Science Animal Health Public Company Limited Announces Cash Dividend for the Period from January 1, 2022 to June 30, 2022, Payable on September 09, 2022	22-08-11	CI
Bio Science Animal Health Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Bio Science Animal Health Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Bio Science Animal Health Public Company Limited has completed an IPO in the amount of THB 564 million.	22-05-03	CI
Bio Science Animal Health Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-02	CI
Bio Science Animal Health Public Company Limited has filed an IPO.	21-11-19	CI

Chart Bio Science Animal Health

Duration

Period

More charts

Company Profile

Bioscience Animal Health Public Company Limited (BIS) is a Thailand-based company. The Company is an importer and distributor of medical supplies, tools, equipment and products for livestock and pets. It focuses on selecting products by specialist veterinarians to improve animal health. The Company's products include antibiotic, additive, BiSMiX B-Series, BiSMiX SD Series, injection, mold inhibitor, water-soluble products, and vaccine. The antibiotic includes Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. The injection consists of Zuprevo, Nuflor, Ceva and Enzaprost. Its services include comprehensive farm advisor, disease prevention and surveillance program, serological examination and diagnosis program, biosafety and hygiene management program, analysis of feed raw materials, preparation of feed formulations, feed production inspection and monitoring program, management and upskilling of farm personnel.

Sector

Healthcare Facilities & Services

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
BIO SCIENCE ANIMAL HEALTH	-24.49%	32.96M
HCA HEALTHCARE, INC.	+16.78%	83.47B
CVS HEALTH CORPORATION	-31.74%	69.72B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-3.24%	26.37B
FRESENIUS SE & CO. KGAA	+4.13%	17.86B
LABCORP HOLDINGS INC.	-13.41%	16.83B
QUEST DIAGNOSTICS INCORPORATED	+0.69%	15.7B
NATERA, INC.	+73.37%	13.45B
TENET HEALTHCARE CORPORATION	+72.18%	12.81B
REDE D'OR SÃO LUIZ S.A.	-2.64%	12.44B

Other Healthcare Facilities & Services